Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Chromosomal Instability: early-phase trial registry

1 of 2 indexed Chromosomal Instability trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Chromosomal Instability: 2 US clinical trials tracked, 1 recruiting.

Chromosomal Instability is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Volastra Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition chromosomal-instability

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chromosomal Instability (thi…50%
Open-enrollment share among volume-matched conditions near Chromosomal Instability

Chromosomal Instability lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chromosomal Instability on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chromosomal Instability is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Top Sponsors

Named interventions

Most-linked intervention names on Chromosomal Instability records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sovilnesib Drug
1 trials
VLS-1488 Drug
1 trials

US sites by state

Facility locations filed on Chromosomal Instability trials. A trial with sites in several states counts in each.

New York 2 trials
Michigan 2 trials
Maryland 2 trials
California 2 trials
Wisconsin 1 trials
Washington 1 trials
Texas 1 trials
South Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chromosomal Instability page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Chromosomal Instability trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Volastra Therapeutics sponsors the most Chromosomal Instability trials on record, review their full trial history before evaluating a specific study. See Volastra Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chromosomal Instability condition card totals 2 registered trials; most-linked intervention Sovilnesib; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.